Ftse Mib
36.471,75
0,12%
DAX
21.732,05
0,01%
S&P 500
6.040,53
-0,50%
NASDAQ
19.627,44
-0,28%
Bitcoin
101.894,53
-0,51%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Rigel Pharmaceuticals Inc (RIGL) Rigel Pharmaceuticals Inc (RIGL) Notizie

RIGL

Rigel Pharmaceuticals (RIGL)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:RIGL
DataOraFonteTitoloSimboloCompagnia
01/02/202500:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RIGLRigel Pharmaceuticals Inc
24/01/202522:38Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RIGLRigel Pharmaceuticals Inc
22/01/202514:05PR Newswire (US)Rigel's Fostamatinib Being Studied by National Institute of Health in Patients with Sickle Cell DiseaseNASDAQ:RIGLRigel Pharmaceuticals Inc
13/01/202514:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RIGLRigel Pharmaceuticals Inc
13/01/202514:05PR Newswire (US)Rigel Provides Business Update and 2025 OutlookNASDAQ:RIGLRigel Pharmaceuticals Inc
09/01/202514:05PR Newswire (US)Rigel Announces R289 Granted Orphan Drug Designation by the FDA for MDSNASDAQ:RIGLRigel Pharmaceuticals Inc
08/01/202514:05PR Newswire (US)Rigel to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:RIGLRigel Pharmaceuticals Inc
03/01/202514:05PR Newswire (US)Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)NASDAQ:RIGLRigel Pharmaceuticals Inc
09/12/202418:02PR Newswire (US)Rigel Highlights Initial Data from Ongoing Phase 1b Study Evaluating R289 in LR-MDS at the 66th ASH Annual Meeting and ExpositionNASDAQ:RIGLRigel Pharmaceuticals Inc
02/12/202414:05PR Newswire (US)Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk MDSNASDAQ:RIGLRigel Pharmaceuticals Inc
14/11/202423:18Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:RIGLRigel Pharmaceuticals Inc
12/11/202414:05PR Newswire (US)Rigel to Present at the Jefferies London Healthcare ConferenceNASDAQ:RIGLRigel Pharmaceuticals Inc
07/11/202422:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RIGLRigel Pharmaceuticals Inc
07/11/202422:01PR Newswire (US)Rigel Reports Third Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:RIGLRigel Pharmaceuticals Inc
05/11/202415:05PR Newswire (US)Rigel Announces Six Poster Presentations at the 66th American Society of Hematology Annual Meeting and ExpositionNASDAQ:RIGLRigel Pharmaceuticals Inc
31/10/202413:05PR Newswire (US)Rigel Announces Conference Call and Webcast to Report Third Quarter 2024 Financial Results and Business UpdateNASDAQ:RIGLRigel Pharmaceuticals Inc
24/10/202422:35PR Newswire (US)Rigel Pharmaceuticals Issues Dear Healthcare Provider Letter for GAVRETO® (pralsetinib)NASDAQ:RIGLRigel Pharmaceuticals Inc
16/10/202416:00GlobeNewswire Inc.Optime Care Expands Partnership with Rigel Pharmaceuticals to Include Commercial Distribution for TAVALISSE®NASDAQ:RIGLRigel Pharmaceuticals Inc
04/10/202414:05PR Newswire (US)Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)NASDAQ:RIGLRigel Pharmaceuticals Inc
12/09/202414:05PR Newswire (US)Rigel to Present at the 2024 Cantor Global Healthcare ConferenceNASDAQ:RIGLRigel Pharmaceuticals Inc
05/09/202413:30PR Newswire (US)Rigel Announces First Patient Enrolled in Phase 1b/2 Triplet Therapy Trial of REZLIDHIA® (olutasidenib) in mIDH1 AMLNASDAQ:RIGLRigel Pharmaceuticals Inc
03/09/202414:00PR Newswire (US)Rigel Expands Relationship with Kissei to include REZLIDHIA® (olutasidenib) in Japan, the Republic of Korea and TaiwanNASDAQ:RIGLRigel Pharmaceuticals Inc
29/08/202414:05PR Newswire (US)Rigel to Participate in Upcoming September Investor ConferencesNASDAQ:RIGLRigel Pharmaceuticals Inc
12/08/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:RIGLRigel Pharmaceuticals Inc
06/08/202423:01Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:RIGLRigel Pharmaceuticals Inc
06/08/202422:01PR Newswire (US)Rigel Reports Second Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:RIGLRigel Pharmaceuticals Inc
02/08/202422:53Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:RIGLRigel Pharmaceuticals Inc
30/07/202414:05PR Newswire (US)Rigel Announces Conference Call and Webcast to Report Second Quarter 2024 Financial Results and Business UpdateNASDAQ:RIGLRigel Pharmaceuticals Inc
25/06/202414:00PR Newswire (US)Rigel Announces Reverse Stock SplitNASDAQ:RIGLRigel Pharmaceuticals Inc
24/06/202422:05PR Newswire (US)Rigel Pharmaceuticals Completes Transfer of GAVRETO® (pralsetinib) New Drug ApplicationNASDAQ:RIGLRigel Pharmaceuticals Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:RIGL

La tua Cronologia

BIT
UC4PPP
Unicredit Bank
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci